|
1
|
Wakao F, Nishimoto H, Katanoda K, et al:
Cancer Statistics in Japan 2015Editorial Board of the Cancer
Statistics in Japan (ed.). Foundation for Promotion of Cancer
Research c/o National Cancer Center; Tokyo: pp. 1–129. 2016
|
|
2
|
Maeda T, Ueda H, Tabata M, Kiura K,
Shibayama T, Gemba K, Takigawa N, Hiraki A, Katayama H and Harada
M: Prognostic factors in advanced non-small cell lung cancer:
Elevated serum levels of neuron specific enolase indicate poor
prognosis. Jpn J Cin Oncol. 30:534–541. 2000. View Article : Google Scholar
|
|
3
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang QZ, Xu W, Habib N and Xu R: Potencial
uses of microRNA in lung cancer diagnosis, prognosis, and theray.
Curr Cnacer Drug Targets. 9:572–594. 2009. View Article : Google Scholar
|
|
5
|
Deng D, Liu Z and Du Y: Epigenetic
alterations as cancer diagnostic, prognostic, and predictive
biomatkers. Adv Genet. 71:125–176. 2010.PubMed/NCBI
|
|
6
|
Grady WM and Tewai M: The next thing in
prognostic molecular markers: MicroRNA signatures of cancer. Gut.
59:706–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Ba Y, Ma I, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characteruzation of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heegaard NH, Schetter AJ, Welsh JA, Yoneda
M, Bowman ED and Harris CC: Circulating micro-RNA expression
profiles in early stage nonsmall cell lung cancer. Int J Cancer.
130:1378–1386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ulivi P and Zoli W: miRNAs as non-invasive
biomarkers for lung cancer diagnosis. Molecules. 19:8220–8237.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Powrózek T, Krawczyk P, Kowalski DM,
Winiarczyk K, Olszyna-Serementa M and Milanowski J: Plasma
circulating microRNA-944 and microRNA-3662 as potential histologic
type-specific early lung cancer biomarkers. Transl Res.
166:315–323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng D, Haddadin S, Wang Y, Gu LQ, Perry
MC, Freter CE and Wang MX: Plasma microRNAs as novel biomarker for
early detection of lung cancer. Int J Clin Exp Pathol. 4:575–586.
2011.PubMed/NCBI
|
|
12
|
Kowal J, Tkach M and Théry C: Biogenesis
and secretion of exosome. Curr Opin Cell Biol. 29:116–125. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z:
miRNA in plasma exosome is stable under different storage
conditions. Molecules. 19:1567–1575. 2014. View Article : Google Scholar
|
|
14
|
Palma J, Yaddannapudi SC, Pigati L, Havens
MA, Jeong S, Weiner GA, Weimer KM, Stern B, Hastings ML and Duelli
DM: MicroRNAs are exported from malignant cells in customized
particles. Nucleic Acids Res. 40:9125–9138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Simons M and Raposo G: Exosomes-vesicular
carriers for intercelluar communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanisms of genetic exchange between cells.
Nat cell Bio. 9:654–659. 2007. View
Article : Google Scholar
|
|
18
|
Hannafon BN and Ding WQ: Intercellular
communication by exosome-derived microRNAs in cancer. Int J Mol
Sci. 14:14240–14269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tanaka Y, Kamohara H, Kinoshita K,
Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H:
Clinical impact of serum exosomal microRNA-21 as a clinical
biomarker in human esophageal squamous cell carcnoma. Cancer.
119:1159–1167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H and Sonoda
H: Circulatung exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sugimachi K, Matsumura T, Hirata H, Uchi
R, Ueda M, Ueo H, Shinden Y, Iguchi T, Eguchi H, Shirabe K, et al:
Idenification of a bona fide microRNA biomarker in serum exosomes
that predicts hepatocellular carcinoma recurrence after liver
transplantation. Br J Cancer. 112:532–538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Travis WD, Brambilla E, Buke AP, Marx A
and Nicholson AG: WHO classification of tumors of the lung, pleura,
thymus and heartBosman FT, Jaffe ES, Lakhani SR and Ohgaki H:
International Agency for Research on Cancer; France: pp. pp1–pp412.
2015
|
|
23
|
General rule for clinical and pathological
record of lung cancer, . The Japan Lung Cancer Society (ed.).
Kenehara Co. Ltd; Tokyo: pp. pp1–pp213. 2014
|
|
24
|
Guidelines 2014 for treatment of lung
cancer by EBM, . Japan Lung Cancer Society (ed.). Kenehara Co. Ltd;
Tokyo: pp. pp1–pp201. 2014
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Li P, Ju H, Pesta M, Kulda V, Jin
W, Cai M, Liu C, Wu H, Xu J, et al: Diagnostic and prognostic value
of microRNA-21 in colorectal cancer: An original study and
individual participant data meta-analysis. Cancer Epidemiol
Biomarkers Prev. 23:2783–2792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang
KM and De W: Prognostic significance of serum miRNA-21 expression
in human non-small cell lung cancer. J Surg Oncol. 104:847–851.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sanfiorenzo C, Iiie MI, Belaid A, Barlési
F, Mouroux J, Marquette CH, Brest P and Hofman P: Two panels of
plasma microRNAs as non-invasive biomarkers for prediction of
recurrence in resectable NSCLC. PLoS One. 8:e545962013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao F, Chang J, Wang H and Ahang G:
Potential diagnostic value of miR-155 in serum from lung
adenocarcinoma patients. Oncol Rep. 31:351–357. 2014.PubMed/NCBI
|
|
30
|
Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ,
Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum
miR-21 and tumor miR-200c associated with poor prognosis in
patients with lung cancer. Med Oncol. 29:618–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Motoyama K, Onoue H, Mimori K, Tanaka F,
Kojima K, Uetake H, Sugihara K and Mori M: Clinicopathological and
prognostic significance of pdcd4 and microRNA-21 in human gastric
cancer. Int J Oncol. 36:1089–1095. 2010.PubMed/NCBI
|
|
34
|
Horiuchi A, Iinuma H, Akahane T, Shimada R
and Watanabe T: Prognostic significance of PDCD4 expression and
association with microRNA-21 in each Dukes' stage of colorectal
cancer patients. Oncol Rep. 27:1384–1392. 2012.PubMed/NCBI
|
|
35
|
Bai R, Shi Z, Zhang JW, Li D, Zhu YL and
Zheng S: ST13, a proliferation regulator, inhibits growth and
migration of colorectal cancer cell lines. J Zhejiang Univ Sci B.
13:884–893. 2012. View Article : Google Scholar : PubMed/NCBI
|
